Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Commission responds to "easy market access" claims

This article was originally published in RAJ Devices

Executive Summary

The European Commission is unable to say whether market access for medical devices is easier in the European Union than it is in the US, as has been suggested1,2. Any comparative advantage of the EU with regard to easy market access that does exist, however, will “slightly shrink” when new requirements for clinical investigation become effective, the commission says, adding that there is nothing wrong with easy access as long as it is not linked to a low safety standard.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts